If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
456.00    1.00 (0.22%)
Bid:
443.00
Ask:
459.00
Spread: 16.00 (3.612%)
Market Cap: £225.14m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update

8 Jun 2009 07:00

RNS Number : 4814T
City of London Investment Group PLC
08 June 2009
 



CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group")

tRADING UPDATE FOR THE YEAR TO 31 MAY 2009

City of London (AIM: CLIG), a leading emerging markets asset management group, provides a trading update for the financial year ended 31 May 2009. The numbers that follow are all unaudited.

The Group has added new clients over the period despite the significant market declines. Funds under management ("FuM") were $3.50 billion (£2.17 billion) at 31 May 2009. This compares with $4.71 billion (£2.38 billion) at 31 May 2008, a decline of 26%, versus a fall of 36% in the MSCI Emerging Markets Index (MXEF) over the same period. With revenues almost entirely dollar denominated, the Group has benefitted throughout most of the period under review from the relative weakness of sterling.

A measure of the group's success in growing FuM during what most would see as an exceptionally difficult year can be found by referencing the opening and closing FuM to the index, MXEF. At 31st May 2008, the group was managing $4.7 billion, with MXEF at 1,207. The equivalent FuM re-based to the 31st May 2009 MXEF level of 773 would be $3.0 billion, so the additional $0.5 billion represents an underlying growth rate of just under 17%. Looked at in the same way, since the apparent peak of $4.95 billion in October 2007, underlying FuM have actually grown by 24%. In addition to the stated year end FuM, awarded but unfunded mandates total a further $517 million.

For the year to 31 May 2009, City of London expects that pre-tax profits will be approximately £5.4 million (2008: £10.7 million) and that profits after an anticipated tax charge of £1.6 million (29% of pre-tax profits) will be approximately £3.8 million (2008: profits of £7.1 million after a tax charge of £3.6 million, representing 34% of pre-tax profit). Basic and fully diluted earnings per share are expected to be 15.9p and 14.8p respectively (2008: 29.3p and 26.1p).

With FuM at significantly lower levels through the second and third quarters, fee income at an expected £20.3 million represents a decrease of around 19% compared to last year's £24.9 million, the fall having been cushioned by sterling weakness. That weakness however has had an adverse impact on costs, with overheads approximately 29% higher, but variable costs, which this year should form circa 46% of the total cost base (2008: 60%), fall from £9.0 million to around £6.7 million, and as a result total "administrative expenses" are expected to be £14.5 million as compared to last year's £15.0 million.

The Group's dividend policy is unchanged, based on paying dividends that are covered approximately one and a half times by full year earnings per share, but a temporary reduction in earnings cover is intended this year in recognition of exceptional market conditions, and within the context of a strong cash position and an improving outlook. An interim dividend of 5p (2007/8: 6p) was paid in March, and in line with this and based upon the customary one thirds/two thirds split, the Board is recommending a final dividend of 10p per share (2008: 13.5p), making a total for the year of 15p (2008: 19.5p), covered 1.06 times by earnings per share (2008: 1.50 times). It is relevant to note that a substantial recovery of corporation tax, not far short of £1 million, has been accrued to reflect the allowable cost of share option exercises, but that in accordance with IAS12 this credit has for the most part been taken directly to reserves. While this tax adjustment therefore provides no earnings cover, it will upon receipt increase cash cover, and the Board proposes to take this into account when considering next year's interim dividend.

In keeping with the optimism expressed at the interim stage, the Group has continued to progress organic expansion with four senior appointments during the year. In the US, a fund manager was appointed to support the first mandate for a product investing via closed end funds in developed markets, which is expected to total US$100 million once funded. To implement the Group's decision to bring its US marketing in-house and reduce third party commissions, a marketing manager has been appointed to develop our direct relationship with the consultant industry which advises institutional investors.

In the UK, a senior fund manager specialising in Asian investment was appointed to provide the expertise necessary to develop The Asian Value & Growth Fund (a spoke of the World Markets Umbrella Fund), which will invest directly in equities in Emerging Asia. This will be launched on 1 July 2009, to be marketed initially to investors in the UK, and ultimately to the Group's client base in North America. A business development manager has been appointed to support the Group's objective to further strengthen City of London's relationships in the UK and European institutional markets.

In the prior Funds Under Management Update (9 March 2009), we remained 'unfashionably optimistic' regarding our asset class. At that point MXEF was 7.5% above the low point reached in October 2008. On 29 May 2009, MXEF closed 70% above that low and, whilst we certainly remain positive regarding the long-term prospects for emerging markets relative to developed markets, we believe that the index has probably advanced at what will prove to have been an unsustainable rate. We therefore expect that there will likely be a retrenchment within the coming months.

City of London Investment Group expects to announce final full year results for the year to 31 May 2009 on 14 September 2009.

Summary and trading update

Year to 31 May

2008

2009

Funds under Management (at period end)

US$4.7bn

US$3.5bn

Turnover (plus investment income)

£25.7m

£20.4m

Administrative expenses

£15.0m

£14.5m

Profit before tax

£10.7m

£5.4m

Profit after tax

£7.1m

£3.8m

Profit per share, basic

29.3p

15.9p

Profit per share, diluted

26.1p

14.8p

Financials - consolidated income statement

Year to 31 May

£'000

2008

2009

Fee income

24,879

20,250

Interest & other

869

(393)

Finder's commission

(3,559)

(3,036)

Custody & Administration

(775)

(898)

Total net income

20,982

15,923

Costs:

Human resources

3,640

4,390

Premises

291

447

Communications & IT

838

1,506

Business development

442

386

General

826

1,053

Total costs

6,037

7,782

Operating profit

15,377

8,141

Profit-share

4,682

2,764

Pre-tax profit

10,695

5,377

Tax

(3,559)

(1,581)

Post-tax profit

7,136

3,796

Dividends *

(3,237)

(4,418)

Retained

3,904

(622)

* prior year final plus current year interim

-ends-

For further information, please visit www.citlon.co.uk or contact:

Doug Allison (Finance Director)

Simon Hudson / Andrew Dunn

City of London Investment Group PLC

Tavistock Communications

Tel: +44 (0) 20 7860 8347

Tel: +44 (0)20 7920 3150

Jeff Keating 

Tom Price / Chris Sim

Singer Capital Markets Ltd

Evolution Securities Limited

Nominated Adviser & Joint Broker

Joint Broker

Tel: +44 (0)20 3205 7500

Tel: +44 (0)20 7071 4300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTILFVERSIEIIA
Date   Source Headline
20th Mar 200911:20 amRNSHolding(s) in Company
12th Mar 20093:05 pmRNSDirector/PDMR Shareholding
9th Mar 20097:00 amRNSFUM Update
2nd Mar 20095:42 pmRNSDirector/PDMR Shareholding
20th Feb 20094:09 pmRNSDividend reinvestment plan
11th Feb 20094:55 pmRNSHolding(s) in Company
9th Feb 200911:03 amRNSDirector/PDMR Shareholding
4th Feb 20093:16 pmRNSDirector/PDMR Shareholding
4th Feb 200912:04 pmRNSHolding(s) in Company
30th Jan 20099:32 amRNSTotal Voting Rights
28th Jan 20094:02 pmRNSDirector/PDMR Shareholding & TVR
28th Jan 20097:00 amRNSHalf Yearly Report
21st Jan 200912:16 pmRNSHolding(s) in Company
13th Jan 20099:00 amRNSBlock Admission & TVR
8th Dec 20087:34 amRNSFunds under Management - Replacement
8th Dec 20087:00 amRNSFunds Under Management
27th Nov 20084:31 pmRNSDirector/PDMR Shareholding
7th Nov 20089:09 amRNSDirector/PDMR Shareholding
3rd Nov 20087:00 amRNSChange of Registered Office
28th Oct 20087:00 amRNSResult of AGM
27th Oct 20087:00 amRNSAGM Trading Update
8th Oct 200810:01 amRNSChange of Adviser Name
30th Sep 200812:18 pmRNSDirector/PDMR Shareholding
30th Sep 200810:04 amRNSDirector/PDMR Shareholding
22nd Sep 20081:04 pmRNSNotifiable Interest
15th Sep 20087:00 amRNSFinal Results
14th Jul 20086:03 pmRNSDirector/PDMR Shareholding
10th Jun 20087:00 amRNSDirector/PDMR Shareholding
9th Jun 20087:00 amRNSTrading Update
19th May 20082:34 pmRNSDirectorate Change
28th Apr 20083:50 pmRNSNotifiable Interest
23rd Apr 20087:00 amRNSNotifiable Interest
18th Apr 20085:00 pmRNSNotifiable Interest
18th Apr 20083:36 pmRNSDirector/PDMR Shareholding
31st Mar 20089:56 amRNSTotal Voting Rights
27th Mar 20087:01 amRNSDirector/PDMR Shareholding
26th Mar 20082:24 pmRNSAppointment of Joint Broker
17th Mar 200810:51 amRNSNotifiable Interest
10th Mar 20087:00 amRNSFunds Under Management
29th Feb 20085:01 pmRNSNotifiable Interest
29th Feb 20085:00 pmRNSNotifiable Interest
29th Feb 20087:01 amRNSBuyback & Directors' Dealing
7th Feb 20089:57 amRNSDirector/PDMR Shareholding
6th Feb 20087:01 amRNSDirector/PDMR Shareholding
29th Jan 20087:00 amRNSInterim Results
18th Jan 200811:47 amRNSNotice of Results Correction
18th Jan 20089:07 amRNSNotice of Results
10th Dec 20077:00 amRNSFunds Under Management
30th Nov 20077:01 amRNSDirector/PDMR Shareholding
29th Oct 200712:44 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.